- Latest available (Revised)
- Original (As adopted by EU)
Commission Regulation (EU) No 1066/2013 of 30 October 2013 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
There are currently no known outstanding effects for the Commission Regulation (EU) No 1066/2013.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Application — Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
---|---|---|---|
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Glucosamine | Glucosamine contributes to the protection of joint cartilage exposed to excessive motion or loading and helps to improve the range of motion in joints | Q-2011-00907 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Glucosamine | Glucosamine contributes to the maintenance of normal joint cartilage | Q-2011-01113 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Wheat polar lipid extract | Contributes to improve skin hydration | Q-2011-01122 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Saccharomyces cerevisiae var. boulardii CNCM I-3799 | Saccharomyces cerevisiae var. boulardii CNCM I-3799 helps maintain intestinal comfort | Q-2012-00271 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | A combination of thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, D-biotin and pumpkin seed oil (Cucurbita pepo L.) | Helps to increase hair number | Q-2012-00334 & Q-2012-00335 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Rhodiola rosea L. extract | Helps to reduce tiredness in case of stress | Q-2012-00336 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | A combination of flaxseed oil and vitamin E | Contributes to maintain skin permeability barrier function | Q-2012-00337 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Opti EFAX™ | Opti EFAX™ helps to maintain healthy blood levels of LDL cholesterol | Q-2012-00339 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Opti EFAX™ | Opti EFAX™ helps to maintain healthy blood levels of HDL cholesterol | Q-2012-00340 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | KF2BL20 | Helps to maintain hair strength | Q-2012-00381 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Hyaluronic acid | Helps to maintain good skin hydration | Q-2012-00382 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Opti EFAX™ | Opti EFAX™ helps to maintain healthy blood levels of triglycerides | Q-2012-00383 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Transitech® | Improves transit and durably regulates it | Q-2012-00296 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Femilub® | Helps to reduce vaginal dryness | Q-2012-00571 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | A combination of lycopene, vitamin E, lutein and selenium | Helps to prepare sensitive skin from the inside to improve their tolerance to the sun | Q-2012-00592 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Prolibra® | Helps to reduce body fat while preserving lean muscle | Q-2012-00001 |
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Eff EXT™ | Helps to support joint function by maintaining low levels of plasma C-reactive protein | Q-2012-00386 |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: